すべての画像(2)
About This Item
実験式（ヒル表記法）:
Ru
CAS番号:
分子量:
101.07
MDL番号:
UNSPSCコード:
12141739
PubChem Substance ID:
NACRES:
NA.23
おすすめの製品
アッセイ
99.9%
フォーム
foil
メーカー／製品名
Goodfellow 580-591-20
抵抗性
7.1 μΩ-cm, 0°C
サイズ×厚み
25x25 mm × 1.0 mm
bp
3900 °C (lit.)
mp
2310 °C (lit.)
密度
12.45 g/cm3 (lit.)
SMILES記法
[Ru]
InChI
1S/Ru
InChI Key
KJTLSVCANCCWHF-UHFFFAOYSA-N
類似した製品をお探しですか？ 訪問 製品比較ガイド
詳細
For updated SDS information please visit www.goodfellow.com.
法的情報
Goodfellow製品
保管分類コード
13 - Non Combustible Solids
WGK
nwg
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
GF58059120-1EA:
最新バージョンのいずれかを選択してください：
E Tfouni et al.
Current medicinal chemistry, 17(31), 3643-3657 (2010-09-18)
The discovery of the involvement of nitric oxide (NO) in several physiological and pathophysiological processes launched a spectacular increase in studies in areas such as chemistry, biochemistry, and pharmacology. As a consequence, the development of NO donors or scavengers for
Aviva Levina et al.
Metallomics : integrated biometal science, 1(6), 458-470 (2009-11-01)
Interest in Ru anticancer drugs has been growing rapidly since NAMI-A ((ImH(+))[Ru(III)Cl(4)(Im)(S-dmso)], where Im = imidazole and S-dmso = S-bound dimethylsulfoxide) or KP1019 ((IndH(+))[Ru(III)Cl(4)(Ind)(2)], where Ind = indazole) have successfully completed phase I clinical trials and an array of other
Martin R Gill et al.
Chemical Society reviews, 41(8), 3179-3192 (2012-02-09)
In the last few decades, coordination complexes based on d(6) metal centres and polypyridyl ligand architectures been developed as structure- and site-specific reversible DNA binding agents. Due to their attractive photophysical properties, much of this research has focused on complexes
A Bergamo et al.
Journal of inorganic biochemistry, 106(1), 90-99 (2011-11-25)
The study of metal complexes for the treatment of cancer diseases has resulted in the identification of some unique properties of ruthenium-based compounds. Among these inorganic-based agents, two of them, namely the ruthenium(III) drugs NAMI-A and KP1019 have undertaken with
Lijuan Xiao et al.
The Analyst, 139(16), 4044-4050 (2014-06-19)
In this work, Pt/Au bimetallic nanoparticles (Pt/Au NPs) were used as nanocarriers to develop an electrochemiluminescence (ECL) immunosensor for sensitive cardiac troponin I (cTnI) detection, coupling with enzyme-based signal amplification. First, gold nanoparticles modified Ru(phen)3(2+)-doped silica nanoparticles (Au@RuSiO2 NPs) with
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）